174 related articles for article (PubMed ID: 37240016)
1. Identification of Potential Biomarkers for Diagnosis of Patients with Methamphetamine Use Disorder.
Jang WJ; Song SH; Son T; Bae JW; Lee S; Jeong CH
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240016
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional Profiling of Whisker Follicles and of the Striatum in Methamphetamine Self-Administered Rats.
Jang WJ; Son T; Song SH; Ryu IS; Lee S; Jeong CH
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238484
[TBL] [Abstract][Full Text] [Related]
3. Uncovering transcriptomic biomarkers for enhanced diagnosis of methamphetamine use disorder: a comprehensive review.
Jang WJ; Lee S; Jeong CH
Front Psychiatry; 2023; 14():1302994. PubMed ID: 38260797
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry-based metabolomics in hair from current and former patients with methamphetamine use disorder.
Seo MJ; Song SH; Kim S; Jang WJ; Jeong CH; Lee S
Arch Pharm Res; 2021 Oct; 44(9-10):890-901. PubMed ID: 34741727
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Korean patients with methamphetamine use disorder based on the quantitative analysis of methamphetamine and amphetamine in hair.
Seo MJ; Song SH; Kim S; Jang WJ; Jeong CH; Lee S
Arch Pharm Res; 2020 Aug; 43(8):798-807. PubMed ID: 32737848
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
Stauffer CS; Moschetto JM; McKernan SM; Hsiang E; Borsari B; Woolley JD
Trials; 2019 Feb; 20(1):145. PubMed ID: 30791944
[TBL] [Abstract][Full Text] [Related]
7. Disrupted brain network dynamics and cognitive functions in methamphetamine use disorder: insights from EEG microstates.
Chen T; Su H; Zhong N; Tan H; Li X; Meng Y; Duan C; Zhang C; Bao J; Xu D; Song W; Zou J; Liu T; Zhan Q; Jiang H; Zhao M
BMC Psychiatry; 2020 Jun; 20(1):334. PubMed ID: 32580716
[TBL] [Abstract][Full Text] [Related]
8. Differences in clinical features and gut microbiota between individuals with methamphetamine casual use and methamphetamine use disorder.
He L; Yang BZ; Ma YJ; Wen L; Liu F; Zhang XJ; Liu TQ
Front Cell Infect Microbiol; 2023; 13():1103919. PubMed ID: 36909722
[TBL] [Abstract][Full Text] [Related]
9. Lack of longitudinal changes in cognition in individuals with methamphetamine use disorder during the first 6 weeks after commencing treatment.
Fitzpatrick RE; Robinson AH; Rubenis AJ; Lubman DI; Verdejo-Garcia A
Am J Drug Alcohol Abuse; 2021 May; 47(3):383-392. PubMed ID: 33524275
[No Abstract] [Full Text] [Related]
10. Model-based and model-free mechanisms in methamphetamine use disorder.
Robinson AH; Mahlberg J; Chong TT; Verdejo-Garcia A
Addict Biol; 2024 Jan; 29(1):e13356. PubMed ID: 38221809
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatments for methamphetamine addiction: current status and future directions.
Ballester J; Valentine G; Sofuoglu M
Expert Rev Clin Pharmacol; 2017 Mar; 10(3):305-314. PubMed ID: 27927042
[TBL] [Abstract][Full Text] [Related]
12. An electroencephalographic signature predicts craving for methamphetamine.
Tian W; Zhao D; Ding J; Zhan S; Zhang Y; Etkin A; Wu W; Yuan TF
Cell Rep Med; 2024 Jan; 5(1):101347. PubMed ID: 38151021
[TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of DSM-IV and DSM-5 methamphetamine use disorder diagnoses using the Chinese Version of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA).
Ma YJ; Wang YY; Liu MQ; Fang T; Wei ZR; Chen SB; Tan H; Nunez YZ; Zhang XJ; Hao W; Malison RT; Kranzler HR; Gelernter J; Liu TQ; Yang BZ
Drug Alcohol Depend; 2021 Dec; 229(Pt B):109047. PubMed ID: 34710713
[TBL] [Abstract][Full Text] [Related]
14. Decreased Expression of Plasma MicroRNA in Patients with Methamphetamine (MA) Use Disorder.
Zhao Y; Zhang K; Jiang H; Du J; Na Z; Hao W; Yu S; Zhao M
J Neuroimmune Pharmacol; 2016 Sep; 11(3):542-8. PubMed ID: 27108111
[TBL] [Abstract][Full Text] [Related]
15. A brainnetome atlas-based methamphetamine dependence identification using neighborhood component analysis and machine learning on functional MRI data.
Zhou Y; Tang J; Sun Y; Yang WFZ; Ma Y; Wu Q; Chen S; Wang Q; Hao Y; Wang Y; Li M; Liu T; Liao Y
Front Cell Neurosci; 2022; 16():958437. PubMed ID: 36238830
[TBL] [Abstract][Full Text] [Related]
16. Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults.
Han B; Compton WM; Jones CM; Einstein EB; Volkow ND
JAMA Psychiatry; 2021 Dec; 78(12):1329-1342. PubMed ID: 34550301
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine-associated cardiomyopathy: an addiction medicine perspective.
Somma V; Osekowski M; Paratz E; Bonomo Y
Intern Med J; 2023 Jan; 53(1):21-26. PubMed ID: 36693638
[TBL] [Abstract][Full Text] [Related]
18. Altered serum microRNA expression profile in subjects with heroin and methamphetamine use disorder.
Gu WJ; Zhang C; Zhong Y; Luo J; Zhang CY; Zhang C; Wang C
Biomed Pharmacother; 2020 May; 125():109918. PubMed ID: 32036213
[TBL] [Abstract][Full Text] [Related]
19. Impaired social decision-making in males with methamphetamine use disorder.
Li MH; Zhang M; Yuan TF; Rao LL
Addict Biol; 2022 Sep; 27(5):e13204. PubMed ID: 36001418
[TBL] [Abstract][Full Text] [Related]
20. Current and Emerging Treatments for Methamphetamine Use Disorder.
Moszczynska A
Curr Neuropharmacol; 2021; 19(12):2077-2091. PubMed ID: 34344291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
